1.Clinical Observation on Huatan Quyu Formula Improving Cerebral Small Vessel Disease with Phlegm and Blood Stasis Blocking Collateral Pattern via Regulating Glymphatic System Circulation
Xiaofeng HUANG ; Ting YU ; Xuan ZHANG ; Daichao MA ; Yongmei YAN ; Hui ZHANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(13):205-211
ObjectiveTo observe the clinical efficacy and safety of Huatan Quyu formula in treating cerebral small vessel disease (CSVD) with phlegm and blood stasis blocking collateral pattern via randomized controlled trial, and explore its mechanism of improving CSVD by regulating glymphatic system (GS) circulation. MethodsSixty-eight CSVD patients with phlegm and blood stasis blocking collateral pattern in the Department of Encephalopathy, Affiliated Hospital of Shaanxi University of Chinese Medicine from April to December 2024 were selected and randomly divided into an experimental group (34 cases) and a control group, with 34 cases in each group. Both groups received basic Western medicine treatment, while the experimental group additionally received Huatan Quyu formula. After a course of 12 weeks, the following parameters were compared between the two groups before and after treatment. Clinical outcomes were assessed using the Tinetti performance-oriented mobility assessment (POMA), Montreal Cognitive Assessment (MoCA), Scales for Outcomes in Parkinson's Disease-Autonomic (SCOPA-AUT), and traditional Chinese medicine (TCM) syndrome scores of phlegm and blood stasis blocking collateral pattern. Perivascular space (PVS) in the frontal lobe/basal ganglia and cerebrospinal fluid (CSF) flow parameters in the cerebral aqueduct were evaluated by 3.0T brain MRI, cerebrospinal fluid flow imaging, and phase-contrast magnetic resonance imaging (PC-MRI). Then, safety indicators were monitored, and SPSS 25.0 was used for statistical analysis. ResultsSixty-four patients completed the study (32 in each group). ①Baseline data: No statistically significant difference was found between the two group. ②Efficacy indicators: After treatment, the experimental group exhibited significantly improved total POMA, SCOPA-AUT, and TCM syndrome scores (P<0.01), outperforming the control group (P<0.05). No significant change was observed in MoCA scores between the two groups. ③Imaging indicators: The experimental group showed a reduced PVS area alongside significantly increased CSF flow parameters (including downward flow during the systolic period, and upward flow during the diastolic period) (P<0.01), which were superior to the control group (P<0.01). ④Safety: The laboratory indicators were normal in both groups, with no drug-related adverse reactions. ConclusionFor CSVD patients with phlegm and blood stasis blocking collateral pattern, Huatan Quyu formula can safely and effectively improve motor function, autonomic nerve function, and TCM syndromes, with potential mechanisms related to pulsatile CSF flow enhancement and GS circulation efficiency improvement.
2.Mechanistic Study on IRF7-mediated Regulation of Learning and Memory Function by Aerobic Exercise in Aged Mice
Min-Yan ZHENG ; Xiao-Han HUANG ; Chang-Ling WEI ; Yuan-Ting ZHANG ; Yu JIN ; Xue LI
Progress in Biochemistry and Biophysics 2026;53(9):2449-2461
ObjectiveTo explore the mechanism by which aerobic exercise improves hippocampal neuroinflammation and learning and memory ability in brain-aged mice via interferon regulatory factor 7 (IRF7). MethodsA total of 60 male specific pathogen-free (SPF) C57BL/6J mice were enrolled in the experiment, including 30 young mice (2 months old) and 30 naturally aging mice (12 months old). Young mice and old mice were respectively randomly assigned to four groups: young control group (group C, n=15), young exercise group (group CE, n=15), and aging control group (group A, n=15), aging exercise group (group AE, n=15). Mice in the exercise groups received an 8-week continuous treadmill aerobic exercise intervention, while control mice were kept under routine feeding without exercise intervention. After the intervention, Barnes maze and Y-maze behavioral tests were performed to comprehensively assess the learning and memory abilities of each group of mice. Transmission electron microscopy was used to observe the ultrastructural morphological changes of hippocampal synapses. Western blot assay was utilized to detect the protein expression and phosphorylation levels of Janus kinase 1 (JAK1), signal transducer and activator of transcription 1 (STAT1), as well as the expression of postsynaptic density protein 95 (PSD95). Immunofluorescence staining was applied to quantify the fluorescence intensity of ionized calcium-binding adapter molecule 1 (IBA1) in hippocampal tissues. The expression levels of inflammatory cytokines including interferon-α (IFN-α), interferon-β (IFN-β), tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were measured by enzyme-linked immunosorbent assay (ELISA). Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to detect the mRNA expression level of IRF7, and DNA methylation assay was further conducted to analyze the methylation level of the IRF7 gene in mouse hippocampus. ResultsAt the molecular level, compared with group C, the protein expression levels of JAK1, STAT1, p‑JAK1, and p‑STAT1 in group A were significantly increased (P<0.05), whereas PSD95 expression was decreased (P<0.05). ELISA assays showed that the levels of IFN‑α, IFN‑β, TNF‑α, and IL‑1β were significantly elevated in group A (P<0.001). RT‑PCR analysis revealed that, compared with group C, the mRNA expression of IRF7 in group A was markedly upregulated (P<0.000 1), while the CpG methylation rate of the IRF7 promoter was significantly reduced (P<0.05). In contrast, all the above parameters in the AE group showed improvements relative to those in group A. Immunofluorescence staining indicated positive IBA1 expression in the brain tissues of group A mice. Exercise intervention reversed these abnormal changes. ConclusionIn aged mice, aerobic exercise induces hypermethylation of the IRF7 promoter region, suppresses IRF7 expression and activation of the downstream IFN‑I/JAK1/STAT1 signaling pathway, accompanied by alleviated neuroinflammation, improved learning and memory, and ameliorated brain aging-related phenotypes.
3.The correlation and diagnostic value of CX3CL1 and CCL5 in peripheral blood with NLRP3 mRNA expression,IL-1β,IL-18 and Treg/Th17 ratio imbalance in AR patients
Yan QIN ; Ting HUANG ; Zhimao ZHANG
International Journal of Laboratory Medicine 2025;46(13):1554-1560
Objective To investigate the correlation and diagnostic value of C-X3-C motif chemokine ligand 1(CX3CL1)and C-C motif chemokine ligand 5(CCL5)in peripheral blood with NOD-like receptor thermal protein domain associated protein 3(NLRP3)mRNA expression,interleukin(IL)-1β,IL-18 and T regulatory cells(Treg)/T helper cells 17(Th17)ratio imbalance in allergic rhinitis(AR)patients.Methods A total of 143 patients with AR admitted to the hospital from January to October 2023 were selected as the AR group,and another 143 healthy volunteers who underwent physical examinations in the hospital during the same peri-od were selected as the control group.The AR group was divided into the moderate-to-severe AR group and the mild AR group according to the severity of AR.Pearson and Spearman correlation analyses were used to analyze the correlations between the expressions of CX3CL1 and CCL5 in the peripheral blood of AR patients and NLRP3 mRNA,as well as serum IL-1β,IL-18,Treg,Th17,and the ratio of Treg/Th17.Univariate analy-sis and multivariate Logistic regression were used to analyze the influencing factors of AR,and the receiver op-erating characteristic(ROC)curve was used to analyze the diagnostic value of peripheral blood CX3CL1,CCL5,NLRP3 mRNA,and the ratio of Treg/Th17 for AR.Results Compared with the control group,the levels of CX3CL1 and CCL5 in the peripheral blood of the mild AR group and the moderate to severe AR group increased,and the difference was statistically significant(P<0.05).The proportions of IL-1β,IL-18,Th17 cells and the expression of NLRP3 mRNA in the moderate to severe AR group were higher than those in the mild AR group,while the proportion of Treg cells and the ratio of Treg/Th17 were lower than those in the mild AR group,and the differences were statistically significant(P<0.05).CX3CL1 and CCL5 were positive-ly correlated with the proportions of IL-1β,IL-18,Th17 cells and the expression of NLRP3 mRNA,and nega-tively correlated with the proportion of Treg cells and the ratio of Treg/Th17(P<0.05).Compared with the control group,the proportion of family history of AR,total immunoglobulin E,the proportion of dust exposure to residence or occupation,the proportions of CX3CL1,CCL5,IL-1β,IL-18,Th17 cells and the expression of NLRP3 mRNA in the AR group increased,while the proportion of Treg cells and the ratio of Treg/Th17 de-creased,the difference was statistically significant(P<0.05).The results of multivariate Logistic regression analysis showed that family history of AR,exposure to dust in residence or occupation,NLRP3 mRNA,CX3CL1,and CCL5 were independent risk factors for the onset of AR,and the ratio of Treg/Th17 was an in-dependent protective factor(P<0.05).The results of ROC curve analysis showed that the area under the curve of the four combined diagnoses of peripheral blood CX3CL1,CCL5,NLRP3 mRNA,and the ratio of Treg/Th17 for AR was 0.945.They were greater than 0.808,0.790,0.800,and 0.797 of CX3CL1,CCL5,NL-RP3 mRNA,and the ratio of Treg/Th17 in peripheral blood diagnosed separately(Z=6.245,5.715,5.881,5.347,P<0.001).Conclusion The elevated levels of CX3CL1 and CCL5 in peripheral blood are related to the severity of AR.Both may be involved in the occurrence and development of AR by regulating the NLRP3 in-flammasome and the imbalance of the Treg/Th17 ratio.The combined detection of CX3CL1,CCL5,NLRP3 mRNA and the ratio of Treg/Th17 has certain diagnostic value for AR.
4.Ultrasound Characteristics of Breast Cancer with Different Gene Expression:A Comparative Study
Meiling HUANG ; Lin SANG ; Jingjing XIAO ; Changjiao YAN ; Ting WANG
Chinese Journal of Medical Imaging 2025;33(10):1063-1071
Purpose To explore the ultrasound characteristics of female breast cancer patients with different molecular types,and improve the diagnostic value of ultrasound.Materials and Methods The ultrasound diagnostic data of breast cancer patients in Xijing Hospital,the Air Force Medical University from January 2021 to July 2023 were retrospectively analyzed,and the ultrasound diagnosis of breast cancer patients from the aspects of molecular typing and related human epidermal growth factor receptor-2(HER-2)expression and Ki-67 expression were analyzed.Results A total of 1 405 patients were included in this study,including 240 patients with Luminal A type,631 patients with Luminal B type,162 patients with HER-2+hormone receptor(HR)-type,207 patients with HER-2+HR+type and 165 patients with triple-negative breast cancer.Among the ultrasound characteristics of female breast cancer with different molecular classifications,there were statistical differences in breast imaging reporting and data system classification,edge angulation,spiculation,posterior echo and calcification(χ2=13.652-143.178,all P<0.05).According to the analysis of different degrees of invasion,there were statistical differences in breast imaging reporting and data system classification,edge angulation,spiculation,posterior echo and calcification from the Lumina group(Luminal A,Luminal B)and the aggressive group(HER-2+HR-,HER-2+HR+and triple-negative)(χ2=4.702-17.587,all P<0.05).The HER-2-negative and HER-2-positive groups of patients had significant differences in shape,edge angulation,spiculation and calcification,with statistical differences(χ2=3.947-7.944,all P<0.05).According to the Ki-67 level analysis,it was found that edge angulation,spiculation and posterior echo were influencing factors,with statistical differences(χ2=9.309-56.380,all P<0.05).Conclusion Breast cancer with different molecular expression has its own ultrasound characteristics.Preoperative ultrasound can provide a certain reference basis for the diagnosis,treatment and prognosis assessment of breast cancer.
5.Value of the deep learning automated quantification of tumor-stroma ratio in predicting efficacy and prognosis of neoadjuvant therapy for breast cancer based on residual cancer burden grading
Ting XIE ; Aoling HUANG ; Lingyan XIANG ; Haochen XUE ; Zhengzhuo CHEN ; Aolong MA ; Honglin YAN ; Jingping YUAN
Chinese Journal of Pathology 2025;54(1):59-65
Objective:To investigate the prognostic value of deep learning-based automated quantification of tumor-stroma ratio (TSR) in patients undergoing neoadjuvant therapy (NAT) for breast cancer.Methods:Specimens were collected from 209 breast cancer patients who received NAT at Renmin Hospital of Wuhan University from October 2019 to June 2023. TSR levels in pre-NAT biopsy specimens were automatically computed using a deep learning algorithm and categorized into low stroma (TSR≤30%), intermediate stroma (TSR 30% to ≤60%), and high stroma (TSR>60%) groups. Residual cancer burden (RCB) grading of post-NAT surgical specimens was determined to compare the relationship between TSR expression levels and RCB grades. The correlation of TSR with NAT efficacy was analyzed, and the association between TSR expression and patient prognosis was further investigated.Results:There were 85 cases with low stroma (TSR≤30%), 93 cases with intermediate stroma (TSR 30% to ≤60%), and 31 cases with high stroma (TSR>60%). Different TSR expression levels showed significant differences between various RCB grades ( P<0.05). Logistic univariate and multivariate analyses showed that TSR was a risk factor for obtaining a complete pathological remission from neoadjuvant therapy for breast cancer when it was used as a continuous variable ( P<0.05); COX regression and survival analyses showed that the lower the percentage of tumorigenic mesenchyme was, the better the prognosis of the patient was ( P<0.05). Conclusions:The deep learning-based model enables automatic and accurate quantification of TSR. A lower pre-treatment tumoral stroma is associated with a lower RCB score and a higher rate of pathologic complete response, indicating that TSR can predict the efficacy of neoadjuvant therapy in breast cancer and thus holds prognostic significance. Therefore, TSR may serve as a biomarker for predicting therapeutic outcomes in breast cancer neoadjuvant therapy.
6.Molecular mechanisms and prospects for disease treatment of ciliogenesis and autophagy
Hao-liang HU ; Jin WANG ; Jia-yan LIU ; Shi-fang HUANG ; Yu-ting LI ; Zhe CHEN ; Lin-xi CHEN
Chinese Pharmacological Bulletin 2025;41(4):631-637
Cilia,as cellular sensory organelles,actively partici-pate in and regulate cellular processes such as autophagy and metabolic breakdown during their generation and transportation.Autophagy,on the other hand,is a cell self-protection mecha-nism that maintains cellular homeostasis by clearing aggregates and damaged organelles.Combining recent research findings,this review comprehensively elucidates the bidirectional crosstalk between primary cilia and autophagy.Specifically,it highlights the crucial role of cilia-dependent signaling pathways in activa-ting cellular autophagy and how autophagy regulates cilia genera-tion and length by degrading specific ciliary proteins.Moreover,the dysregulation of primary cilia and autophagy is closely asso-ciated with the clinical manifestations and pathogenesis of vari-ous ciliopathy-related diseases such as polycystic kidney disease and tuberous sclerosis.In terms of pharmacotherapy,this review provides a comprehensive and in-depth overview of small mole-cule inhibitors targeting ciliogenesis,including cytoskeletal drugs and Hedgehog signaling pathway inhibitors.Despite the current limitations in clinical use,these drugs lay the groundw-ork for developing highly specific targeted small molecule inhibi-tors of ciliogenesis and for the treatment of ciliopathies and canc-ers.By systematically discussing ciliogenesis,autophagy,disea-ses and drugs,this review offers new insights for further elucida-ting the crosstalk between ciliogenesis and autophagy,exploring their pathological mechanisms in disease development,and de-veloping therapeutic strategies in the future.
7.Clinical pathology characteristics of thyroid cancer in children, adolescents and young adults
Meiling HUANG ; Changjiao YAN ; Ting WANG
Chinese Journal of General Surgery 2025;40(10):789-795
Objective:To analyze the clinical characteristics of pediatric, adolescent, and young adult thyroid cancer patients treated from Jan 2012 to Jul 2022.Methods:A retrospective analysis was conducted on the pathological and ultrasound features, treatment methods, and survival outcomes of thyroid cancer in three groups: the pediatric group (0-14 years), the adolescent group (15-19 years), and the young adult group (20-39 years).Results:The number of pediatric and adolescent patients showed a relatively stable growth trend, while the proportion of microcarcinomas was significantly higher in the young adult group. Significant differences were observed among the groups in T stage, N stage, M stage, extrathyroidal extension, local invasion, lymph node metastasis, number of metastatic lymph nodes, and tumor hypoechogenicity (all P<0.05). Preoperative thyroid function tests revealed differences in free triiodothyronine (FT3), triiodothyronine (T3), and thyroglobulin (Tg) levels (all P<0.05). All patients underwent thyroidectomy or lobectomy, with significant differences in contralateral neck lymph node dissection rates ( χ2=30.089, P<0.001). Postoperative lymphatic leakage incidence varied ( χ2=8.376, P=0.015), and the proportion of patients receiving postoperative 131I therapy differed significantly ( P<0.001). Significant differences were observed in postoperative recurrence and secondary surgery rates. Multivariate analysis identified FT3, T3, and pathological type as risk factors for recurrence. The three groups showed significant differences in postoperative calcium supplementation upon discharge, with insufficient attention given to bone health and cardiovascular risks. Conclusion:Pediatric, adolescent, and young adult thyroid cancer patients exhibit differences in incidence and pathological characteristics, but no significant difference was found in overall survival.
8.Establishment of a Bortezomib-Resistant Multiple Myeloma Xeno-transplantation Mouse Model by Transplanting Primary Cells from Patients
Yan-Hua YUE ; Yi-Fang ZHOU ; Ying-Jie MIAO ; Yang CAO ; Fei WANG ; Yue LIU ; Feng LI ; Yang-Ling SHEN ; Yan-Ting GUO ; Yu-Hui HUANG ; Wei-Ying GU
Journal of Experimental Hematology 2025;33(1):133-141
Objective:To explore the construction method of a resistant multiple myeloma(MM)patient-derived xenotransplantation(PDX)model.Methods:1.0 × 107 MM patient-derived mononuclear cells(MNCs),2.0 × 106 MM.1S cells and 2.0 × 106 NCI-H929 cells were respectively subcutaneously inoculated into NOD.CB17-Prkdcscid Il2rgtml/Bcgen(B-NDG)mice with a volume of 100 p1 per mouse to establish mouse model.The morphologic,phenotypic,proliferative and genetic characteristics of PDX tumor were studied by hematoxylin-eosin staining,immunohistochemical staining(IHC),cell cycle analysis,flow cytometry and fluorescence in situ hybridization(FISH).The sensitivity of PDX tumor to bortezomib and anlotinib monotherapy or in combination was investigated through cell proliferation,apoptosis and in vitro and in vivo experiments.The effects of anlotinib therapy on tumor blood vessel and cell apoptosis were analyzed by IHC,TUNEL staining and confocal fluorescence microscope.Results:MM PDX model was successfully established by subcutaneously inoculating primary MNCs.The morphologic features of tumor cells from MM PDX model were similar to those of mature plasma cells.MM PDX tumor cells positively expressed CD138 and CD38,which presented 1q21 amplification,deletion of Rb1 and IgH rearrangement,and had a lower proliferative activity than MM cell lines.In vitro,PDX,MM.1S and NCI-H929 cells were treated by bortezomib and anlotinib for 24 hours,respectively.Cell viability assay showed that the IC50 value of bortezomib were 5 716.486,1.025 and 2.775 nmol/L,and IC50 value of anlotinib were 5 5107.337,0.706 and 5.13 μmol/L,respectively.Anlotinib treatment increased the apoptosis of MM.1S cells(P<0.01),but did not affect PDX tumor cells(P>0.05).In vivo,there was no significant difference in PDX tumor growth between bortezomib monotherapy group and control group(P>0.05),while both anlotinib monotherapy and anlotinib combined with bortezomib effectively inhibited PDX tumor growth(both P<0.05).The vascular perfusion and vascular density of PDX tumor were decreased in anlotinib treatment group(both P<0.01).The apoptotic cells in anlotinib treatment group were increased compared with those in control group(P<0.05).Conclusion:Bortezomib-resistant MM PDX model can be successfully established by subcutaneous inoculation of MNCs from MM patients in B-NDG mice.This PDX model,which retains the basic biological characteristics of MM cells,can be used to study the novel therapies.
9.Hematological Characteristics of Neonates with Abnormal Hemoglobin and Their Parents in Guangzhou Area
Yan-Fen GE ; Yue ZHAO ; Ya-Xuan HUANG ; Jun-Ru LIU ; Ting LIN ; Lu-Hua XIAN
Journal of Experimental Hematology 2025;33(1):180-186
Objective:To analyze the incidence of abnormal hemoglobin(Hb)in neonates in Guangzhou area,as well as the results of quantitative analysis of Hb in neonatal umbilical cord blood and genetic diagnosis of thalassemia in neonates with abnormal Hb;And to explore the hematological phenotypes and clinical characteristics of neonates with abnormal Hb and their parents,providing a reference for eugenics and childcare.Methods:650 neonates born at Guangdong Provincial People's Hospital who underwent Hb electrophoresis were included in this study.The results of routine blood test of umbilical cord blood,Hb electrophoresis and α-,β-thalassemia gene detection of the neonates were collected.The genotype distribution of thalassemia in the neonates was analyzed.Additionally,the abnormal Hb content of α and β variants was studied.Furthermore,the differences in hematological parameters between abnormal Hb neonates and normal neonates and α-thalassemia neonates,as well as between the parents of abnormal Hb neonates and normal adults were compared.Results:Among the 650 neonates,332(51.08%)were diagnosed with thalassemia,including 235 cases of α-thalassemia(36.15%),79 cases of β-thalassemia(12.15%),and 18 cases of compound α β-thalassemia(2.77%).Among all the α-thalassemia genotypes,the most prevalent one was--SEA/α α(48.94%),followed by-α3.7/α α(20.00%),-α42/α α(11.06%),and α α CS/α α(8.94%).The four most common genotypes of β-thalassemia were β CD41-42(32.91%),βIVS-Ⅱ-654(26.58%),β-28(21.52%),and β E(10.13%),respectively.275 cases of abnormal bands were found in Hb electrophoresis of umbilical cord blood,with a detection rate of 42.31%.The abnormal Hb content ofα-variant in the neonates was significantly higher than that of β-variant(P<0.001).The levels of Hb,MCV,MCH,Hb A,and Hb F in neonates with abnormal Hb were lower than those in normal neonates,while the RDW-CV was higher than that in normal neonates,with statistical significantce(P<0.05).The levels of RBC and Hb A in neonates with abnormal Hb were lower than those in neonates with α-thalassemia,while the level of MCH was higher than that in neonats withα-thalassemia,with statistical significance(P<0.05).The levels of Hb,MCV,MCH,and Hb A in parents of neonates with abnormal Hb were lower than those in normal adults,while the RDW-CV was higher than that in normal adults,and the differences were statistically significant(P<0.05).Conclusion:The abnormal Hb content of α-variant in the neonates is significantly higher than that of β-variant in the neonates in Guangzhou,which can help to presume whether it isα chain or β chain based on the abnormal Hb content,providing a reference for globin gene sequencing.Meanwhile,analysis of various hematological screening-related indicators in neonates in the early stage is beneficial for early warning of the occurrence of abnormal Hb combined with thalassemia,reducing missed diagnoses to a certain extent.
10.Value of the deep learning automated quantification of tumor-stroma ratio in predicting efficacy and prognosis of neoadjuvant therapy for breast cancer based on residual cancer burden grading
Ting XIE ; Aoling HUANG ; Lingyan XIANG ; Haochen XUE ; Zhengzhuo CHEN ; Aolong MA ; Honglin YAN ; Jingping YUAN
Chinese Journal of Pathology 2025;54(1):59-65
Objective:To investigate the prognostic value of deep learning-based automated quantification of tumor-stroma ratio (TSR) in patients undergoing neoadjuvant therapy (NAT) for breast cancer.Methods:Specimens were collected from 209 breast cancer patients who received NAT at Renmin Hospital of Wuhan University from October 2019 to June 2023. TSR levels in pre-NAT biopsy specimens were automatically computed using a deep learning algorithm and categorized into low stroma (TSR≤30%), intermediate stroma (TSR 30% to ≤60%), and high stroma (TSR>60%) groups. Residual cancer burden (RCB) grading of post-NAT surgical specimens was determined to compare the relationship between TSR expression levels and RCB grades. The correlation of TSR with NAT efficacy was analyzed, and the association between TSR expression and patient prognosis was further investigated.Results:There were 85 cases with low stroma (TSR≤30%), 93 cases with intermediate stroma (TSR 30% to ≤60%), and 31 cases with high stroma (TSR>60%). Different TSR expression levels showed significant differences between various RCB grades ( P<0.05). Logistic univariate and multivariate analyses showed that TSR was a risk factor for obtaining a complete pathological remission from neoadjuvant therapy for breast cancer when it was used as a continuous variable ( P<0.05); COX regression and survival analyses showed that the lower the percentage of tumorigenic mesenchyme was, the better the prognosis of the patient was ( P<0.05). Conclusions:The deep learning-based model enables automatic and accurate quantification of TSR. A lower pre-treatment tumoral stroma is associated with a lower RCB score and a higher rate of pathologic complete response, indicating that TSR can predict the efficacy of neoadjuvant therapy in breast cancer and thus holds prognostic significance. Therefore, TSR may serve as a biomarker for predicting therapeutic outcomes in breast cancer neoadjuvant therapy.

Result Analysis
Print
Save
E-mail